BIOMARIN PHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 4BMRN for the last quarter is 666.76 M EUR, and it's 0.78% higher compared to the previous quarter. The net income of Q3 24 is 95.27 M EUR.